Teva Pharmaceutical Industries | TEVA - Operating Expenses

Teva Pharmaceutical Industries reported $4.74B in Operating Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Expenses Change
Abbvie ABBV:US USD 9.62B 590M
ALKERMES ALKS:US USD 325.26M 12.26M
Amarin AMRN:US USD 95.02M 62.25M
Amgen AMGN:US USD 4.61B 695M
AstraZeneca AZN:LN USD 10.11B 376M
Biogen BIIB:US USD 1.84B 650.7M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Coherus Biosciences CHRS:US USD 96.84M 29.03M
Eli Lilly And LLY:US USD 5.47B 200.3M
Emergent Biosolutions EBS:US USD 395.8M 113.8M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Henry Schein HSIC:US USD 3.3B 443M
Horizon Pharma HZNP:US USD 768.1M 3.34M
JAZZ PHA JAZZ:US USD 1.24B 319.62M
Merk MRK:US USD 10.32B 624M
Novartis NOVN:VX USD 11.05B 378M
Pacira Pharmaceuticals PCRX:US USD 181.85M 35.67M
Patterson Companies PDCO:US USD 1.52B 41.18M
Perrigo Ordinary Shares PRGO:US USD 1.12B 57.6M
Pfizer PFE:US USD 19.12B 5.9B
Phibro Animal Health PAHC:US USD 228.8M 9.96M
Revance Therapeutics RVNC:US USD 194.33M 87.83M
Sun Pharmaceuticals SUNP:IN INR 88.94B 5.3B
Supernus Pharmaceuticals SUPN:US USD 132.99M 45.88M
Takeda 4502:JP JPY 949.56B 51.69B
Teva Pharmaceutical Industries TEVA:US USD 4.74B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.31M 191K
Zoetis ZTS:US USD 1.45B 113M